Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Schreiber, M. Busch, S. Kleinman, J. Korelitz (1996)
The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.The New England journal of medicine, 334 26
O'Brien Tr, George, Epstein Js, S. Holmberg, G. Schochetman (1992)
Testing for antibodies to human immunodeficiency virus type 2 in the United States.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 41 RR-12
Howard Thomas (1970)
Immunological Aspects of Liver DiseaseBritish Medical Journal, 3
Stramer Stramer, Brodsky Brodsky, Preston Preston (2001)
Comparative sen‐ sitivity of HBsAg and HBV NAT.Transfusion, 41
G. Schreiber, M. Busch, S. Kleinman, J. Korelitz (1996)
The Risk of Transfusion-Transmitted Viral InfectionsThe New England Journal of Medicine, 334
S. Kucharski (1993)
Fulminant hepatic failure.Critical care nursing clinics of North America, 5 1
Biswas Biswas, Busch Busch, Hsia Hsia (2001)
Comparative sensitivity of HBV NAT and HBsAg donor testing.Transfusion, 41
P. Mied (2002)
BLOOD PRODUCTS ADVISORY COMMITTEE
E. Tabor, M. Yu, I. Hewlett, J. Epstein (2000)
Summary of a workshop on the implementation of NAT to screen donors of blood and plasma for virusesTransfusion, 40
K. Brown, N. Young, B. Alving, L. Barbosa (2001)
Parvovirus B19: implications for transfusion medicine. Summary of a workshopTransfusion, 41
J. Saldanha, W. Gerlich, N. Lelie, P. Dawson, K. Heermann, Alan Heath (2001)
An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniquesVox Sanguinis, 80
Department of Health and Human Services, Food and Drug Administration. Application of nucleic acid testing to blood borne pathogens and emerging technologies
(1998)
Blood plasma safety: plasma product risks are low if good manufacturing practices are followed
Jaime Poniachik, Rodrigo Quera, Andrea Lui (2002)
[Fulminant hepatic failure].Revista medica de Chile, 130 6
(2001)
Comparative sensitivity of HBsAg and HBV NAT. Transfusion 2001;41:8S
(2002)
Early detection of hepatitis B virus infection: comparative sensitivity of HBV DNA detection by PCR and HBsAg detection by a new generation of assays
E. Tabor (1999)
The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1Transfusion, 39
(2001)
Closing the windows on viral transmission by blood transfusion
NAT for screening blood and plasma for viruses have been rapidly developed and implemented for the detection of HCV and HIV‐1. The US FDA has had to develop regulatory policies under conditions not previously encountered, namely the development, improvement, and application of new test technologies occurring at such unprecedented speed that nearly all blood and plasma donations would need to be tested while the methods were still in clinical trials. This rapid pace of development can be clearly seen to extend into the future; NAT procedures for additional viruses and modifications of NAT for greater sensitivity and the rapid detection of many viruses simultaneously are currently under development. It had been clear for several years that the increased sensitivity for detecting HCV and HIV‐1 by NAT would give an added level of safety to the nation's blood and plasma supply and that widespread use at the earliest possible date, even if conducted under investigational exemptions before approval of licenses for NAT systems, would be desirable. Furthermore, the expectation in the late 1990s that NAT screening of plasma for HCV would be required by European regulatory authorities, and the fact that substantial volumes of plasma collected in the United
Transfusion – Wiley
Published: Sep 1, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.